NYSE:MED - Medifast Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$169.56 +6.21 (+3.80 %)
(As of 06/19/2018 08:00 AM ET)
Previous Close$163.35
Today's Range$163.16 - $169.97
52-Week Range$40.00 - $169.97
Volume188,500 shs
Average Volume168,043 shs
Market Capitalization$1.97 billion
P/E Ratio74.04
Dividend Yield1.18%
Beta0.35
Medifast logoMedifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products. It offers bars, bites, pretzels, puffs, oatmeal and cereal crunch products, drinks, hearty choices, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, and soups under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by OPTAVIA, Flavors of Home, and Essential 1 brands. The company sells its products through various channels, including the Internet, call centers, independent health advisors, medical professionals, franchise weight loss clinics, and direct consumer marketing. As of December 31, 2017, it operated 16 franchised Medifast weight control centers in Arizona, California, Louisiana, Minnesota, and Wisconsin; and 18 reseller locations in California, Maryland, and Pennsylvania. The company was founded in 1980 and is headquartered in Baltimore, Maryland.

Receive MED News and Ratings via Email

Sign-up to receive the latest news and ratings for MED and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Miscellaneous food preparations & kindred products
Sub-IndustryPersonal Products
SectorConsumer Staples
SymbolNYSE:MED
CUSIP58470H10
Phone410-581-8042

Debt

Debt-to-Equity RatioN/A
Current Ratio3.43
Quick Ratio2.98

Price-To-Earnings

Trailing P/E Ratio74.04
Forward P/E Ratio46.45
P/E Growth2.98

Sales & Book Value

Annual Sales$301.56 million
Price / Sales6.78
Cash Flow$2.8383 per share
Price / Cash59.74
Book Value$9.10 per share
Price / Book18.63

Profitability

EPS (Most Recent Fiscal Year)$2.29
Net Income$27.72 million
Net Margins10.26%
Return on Equity31.11%
Return on Assets24.07%

Miscellaneous

Employees399
Outstanding Shares12,060,000

Medifast (NYSE:MED) Frequently Asked Questions

What is Medifast's stock symbol?

Medifast trades on the New York Stock Exchange (NYSE) under the ticker symbol "MED."

How often does Medifast pay dividends? What is the dividend yield for Medifast?

Medifast declared a quarterly dividend on Friday, June 15th. Stockholders of record on Friday, June 29th will be paid a dividend of $0.48 per share on Wednesday, August 8th. This represents a $1.92 annualized dividend and a dividend yield of 1.13%. The ex-dividend date of this dividend is Thursday, June 28th. View Medifast's Dividend History.

How were Medifast's earnings last quarter?

Medifast Inc (NYSE:MED) announced its quarterly earnings data on Thursday, May, 3rd. The specialty retailer reported $1.01 EPS for the quarter, topping the Zacks' consensus estimate of $0.86 by $0.15. The specialty retailer earned $98.60 million during the quarter, compared to analysts' expectations of $89.23 million. Medifast had a return on equity of 31.11% and a net margin of 10.26%. Medifast's revenue for the quarter was up 39.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.36 EPS. View Medifast's Earnings History.

When is Medifast's next earnings date?

Medifast is scheduled to release their next quarterly earnings announcement on Tuesday, August, 14th 2018. View Earnings Estimates for Medifast.

What guidance has Medifast issued on next quarter's earnings?

Medifast updated its FY18 earnings guidance on Thursday, May, 3rd. The company provided earnings per share (EPS) guidance of $3.55-3.65 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.24. The company issued revenue guidance of $385-395 million, compared to the consensus revenue estimate of $354.90 million.Medifast also updated its Q2 guidance to $0.94-0.97 EPS.

What price target have analysts set for MED?

2 brokerages have issued 12 month price objectives for Medifast's shares. Their forecasts range from $55.00 to $161.00. On average, they expect Medifast's share price to reach $108.00 in the next twelve months. View Analyst Ratings for Medifast.

Who are some of Medifast's key competitors?

Who are Medifast's key executives?

Medifast's management team includes the folowing people:
  • Mr. Daniel R. Chard, CEO & Director (Age 53)
  • Mr. Timothy G. Robinson CPA, CPA, Chief Financial Officer (Age 56)
  • Mr. Bill Baker, Exec. VP of Information Technology (Age 46)
  • Mr. Jason L. Groves, Exec. VP, Gen. Counsel & Corp. Sec. (Age 47)
  • Mr. Joseph Kelleman, VP of Fin. & Corp. Controller (Age 63)

Has Medifast been receiving favorable news coverage?

Media headlines about MED stock have trended somewhat positive this week, Accern reports. Accern identifies positive and negative news coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Medifast earned a daily sentiment score of 0.15 on Accern's scale. They also assigned media headlines about the specialty retailer an impact score of 46.32 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the next several days.

Who are Medifast's major shareholders?

Medifast's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (12.40%), Millennium Management LLC (2.40%), American Century Companies Inc. (1.82%), Summit Trail Advisors LLC (1.45%), Northern Trust Corp (1.12%) and Old Mutual Global Investors UK Ltd. (1.09%). Company insiders that own Medifast stock include Charles P Connolly, Glenn W Welling, Jeffrey J Brown, Jeremy John Martin, Michael C Macdonald, Ralph Rushton and Simon TP Ridgway. View Institutional Ownership Trends for Medifast.

Which institutional investors are selling Medifast stock?

MED stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., American Century Companies Inc., HL Financial Services LLC, BNP Paribas Arbitrage SA, Seizert Capital Partners LLC, JPMorgan Chase & Co., Wells Fargo & Company MN and GSA Capital Partners LLP. Company insiders that have sold Medifast company stock in the last year include Charles P Connolly, Glenn W Welling, Jeremy John Martin, Michael C Macdonald and Ralph Rushton. View Insider Buying and Selling for Medifast.

Which institutional investors are buying Medifast stock?

MED stock was purchased by a variety of institutional investors in the last quarter, including Summit Trail Advisors LLC, Millennium Management LLC, Prudential Financial Inc., Great Lakes Advisors LLC, Allianz Asset Management GmbH, Allianz Asset Management GmbH, Landscape Capital Management L.L.C. and Old Mutual Global Investors UK Ltd.. Company insiders that have bought Medifast stock in the last two years include Glenn W Welling, Jeffrey J Brown and Simon TP Ridgway. View Insider Buying and Selling for Medifast.

How do I buy shares of Medifast?

Shares of MED can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Medifast's stock price today?

One share of MED stock can currently be purchased for approximately $169.56.

How big of a company is Medifast?

Medifast has a market capitalization of $1.97 billion and generates $301.56 million in revenue each year. The specialty retailer earns $27.72 million in net income (profit) each year or $2.29 on an earnings per share basis. Medifast employs 399 workers across the globe.

How can I contact Medifast?

Medifast's mailing address is 100 International Drive, Baltimore MD, 21202. The specialty retailer can be reached via phone at 410-581-8042 or via email at [email protected]


MarketBeat Community Rating for Medifast (MED)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  181 (Vote Outperform)
Underperform Votes:  206 (Vote Underperform)
Total Votes:  387
MarketBeat's community ratings are surveys of what our community members think about Medifast and other stocks. Vote "Outperform" if you believe MED will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MED will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.